Relation of lower hematocrit to progression from asymptomatic left ventricular dysfunction to symptomatic heart failure (from the Studies of Left Ventricular Dysfunction Prevention Trial)

Sandeep R. Das, Daniel L. Dries, Mark H. Drazner, Clyde W. Yancy, Claudia U. Chae

Research output: Contribution to journalArticle

5 Scopus citations

Abstract

The relation between hematocrit and progression from asymptomatic left ventricular (LV) systolic dysfunction to symptomatic heart failure (HF) was examined in 2,821 patients from the Studies of Left Ventricular Dysfunction Prevention trial. Patients in the lowest hematocrit quartile (hematocrit ≤40%) were at increased risk for the development of HF symptoms (hazard ratio [HR] 1.79, 95% confidence interval [CI] 1.37 to 2.34), first HF hospitalization (HR 2.35, 95% CI 1.52 to 3.62), and death or the development of HF symptoms (HR 1.60, 95% CI 1.28 to 1.99) compared with patients in the highest hematocrit quartile (hematocrit >46%).

Original languageEnglish (US)
Pages (from-to)827-831
Number of pages5
JournalAmerican Journal of Cardiology
Volume96
Issue number6
DOIs
StatePublished - Sep 15 2005

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Relation of lower hematocrit to progression from asymptomatic left ventricular dysfunction to symptomatic heart failure (from the Studies of Left Ventricular Dysfunction Prevention Trial)'. Together they form a unique fingerprint.

  • Cite this